Company Description
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally.
The company operates in two segments, Dental and Medical.
Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.
The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection.
In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications.
Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines.
Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
Country | United States |
IPO Date | Nov 3, 1995 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 17 |
CEO | Jan Adriaan Haverhals |
Contact Details
Address: 425 Eagle Rock Avenue Roseland, New Jersey United States | |
Website | https://www.milestonescientific.com |
Stock Details
Ticker Symbol | MLSS |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000855683 |
CUSIP Number | 59935P209 |
ISIN Number | US59935P2092 |
Employer ID | 13-3545623 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Jan Adriaan Haverhals | President, Chief Executive Officer & Director |
James Hippett J.D. | Senior Vice President of Global Sales & Business Development |
Keisha Harcum | Controller |
Leonard A. Osser | Founder & Vice Chairman |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | 10-Q | Quarterly Report |
Nov 14, 2024 | 8-K | Current Report |
Oct 23, 2024 | 4 | Filing |
Sep 27, 2024 | 8-K | Current Report |
Sep 27, 2024 | 4 | Filing |
Sep 24, 2024 | 4 | Filing |
Aug 30, 2024 | 4 | Filing |
Aug 30, 2024 | 4 | Filing |
Aug 30, 2024 | 4 | Filing |
Aug 30, 2024 | 4 | Filing |